Townhall Media Announces Larry O’Connor As New Editor of Townhall
There's an Eerie Silence From Frey and Walz Over Don Lemon's Church Storming...
Wait, There's No Way a CNN Guest Did This After Getting Roasted by...
Trump Congratulated the Florida Panthers on Their Stanley Cup Win With a Tremendous...
It's Time to Put an End to the Minneapolis Mob
Activist Tried Going Toe-to-Toe With Scott Jennings. It Did Not Go Well for...
AG Uthmeier: Man Accused of Killing Three Near Disney Had Prior Charges Dismissed...
Dr. Oz Raises Concerns About Hospice Fraud in California
Minnesota Nurses Association Urges Medical Professionals to Join Anti-ICE Protests
Justice Department Indicts Four Houston-Area Rideshare Drivers in Kidnapping Scheme
Pennsylvania Dairy Farmers Celebrate the Whole Milk Act
Trump Blasts the Media for Its ICE Obsession, While Tim Walz's Fraud Fades...
America's Three-Party System
China Begins Conducting Massive Military Movements Inside Iran
The Neighborhoods the Silent Generation Built
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos